Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Nick, Duffy"'
Autor:
Lewis Jones, Rebecca Nightingale, Hassan Burhan, Gareth Jones, Kimberley Barber, Helena Bond, Robert Parker, Nick Duffy, Peter Hampshire, Manish Gautam
Publikováno v:
ERJ Open Research, Vol 7, Iss 4 (2021)
Externí odkaz:
https://doaj.org/article/dfa49b675ba84c52b696629e7e26e692
Autor:
Mohamed Barkat, Angela Key, Tamara Ali, Paul Walker, Nick Duffy, Jayne Snellgrove, Francesco Torella
Publikováno v:
Physiological Reports, Vol 9, Iss 7, Pp n/a-n/a (2021)
Abstract Objective Cardiopulmonary exercise testing (CPET) is often used to assess pre‐operative fitness in elderly patients, in whom peripheral arterial disease (PAD) is highly prevalent, but may affect the results of CPET by early lactate release
Externí odkaz:
https://doaj.org/article/d8d5e9f032e1492ea45b89919b183b7d
Autor:
Ian W Seetho, Adela Ramírez-Torres, Amaya Albalat, William Mullen, Harald Mischak, Robert J Parker, Sonya Craig, Nick Duffy, Kevin J Hardy, Jatin G Burniston, John PH Wilding
Publikováno v:
Sleep Science, Vol 8, Iss 2, Pp 58-67 (2015)
Introduction: Obstructive sleep apnoea (OSA) is common in obesity and is associated with cardiovascular and metabolic complications. Continuous positive airway pressure (CPAP) in OSA may lead to physiological changes reflected in the urinary proteome
Externí odkaz:
https://doaj.org/article/6a43a7c325a146419e56822396467fb1
Publikováno v:
Respiratory Medicine. 122:18-22
Pulse Transit Time (PTT) represents a non-invasive marker of sleep fragmentation in OSAS. Little is known regarding PTT in sleepy subjects exhibiting nocturnal Inspiratory Flow Limitation (IFL) in the absence of apneas or desaturation.The IFL cohort
Autor:
Robert J. Parker, Amaya Albalat, Adela Ramirez-Torres, Nick Duffy, Jatin G. Burniston, Sonya Craig, Harald Mischak, Kevin J Hardy, John P.H. Wilding, William Mullen, Ian W. Seetho
Publikováno v:
Sleep Science
Sleep Science, Vol 8, Iss 2, Pp 58-67 (2015)
Sleep Science, Vol 8, Iss 2, Pp 58-67 (2015)
INTRODUCTION: Obstructive sleep apnoea (OSA) is common in obesity and is associated with cardiovascular and metabolic complications. Continuous positive airway pressure (CPAP) in OSA may lead to physiological changes reflected in the urinary proteome
Autor:
Nick Duffy, Angela Key, S. Pintus, Malcolm A. West, Sandy Jack, Matthew G. Parry, Francesco Torella, Lisa Loughney, Paul Walker, Rebecca Asher
Publikováno v:
British Journal of Anaesthesia. 114:878-885
Background Perioperative beta-blockade is widely used, especially before vascular surgery; however, its impact on exercise performance assessed using cardiopulmonary exercise testing (CPET) in this group is unknown. We hypothesized that beta-blocker
Autor:
Nick Duffy, Nicola J Goodson, Ian W. Seetho, Robert J. Parker, Sonya Craig, Kevin J Hardy, John P.H. Wilding
Publikováno v:
Chronic Respiratory Disease. 12:238-246
Obstructive sleep apnoea (OSA) may increase the risk of hyperuricaemia and predispose to gout. The evidence for the effects of OSA on serum urate in severe obesity is limited. This study investigated whether OSA was associated with serum urate in sev
Publikováno v:
Journal of Sleep Research. 23:700-708
Obstructive sleep apnea is associated with obesity and metabolic syndrome, leading to greater cardiovascular risk. Severely obese patients with obstructive sleep apnea may still be at risk of adverse health outcomes, even without previous cardiovascu
Autor:
Angela, Key, Tamara, Ali, Paul, Walker, Nick, Duffy, Mo, Barkat, Jayne, Snellgrove, Francesco, Torella
Publikováno v:
BMJ Open
Introduction Cardiopulmonary exercise test (CPET) is widely used in preoperative assessment and cardiopulmonary rehabilitation. The effect of peripheral arterial disease (PAD) on oxygen delivery (VO2) measured by CPET is not known. The aim of this st
Autor:
Malcolm A. West, Nick Duffy, Angela Key, Matthew G. Parry, Sandy Jack, Paul Walker, Rebecca Asher, Francesco Torella
Publikováno v:
BMJ Open Respiratory Research
BMJ open respiratory research
BMJ open respiratory research
Introductionβ Blockers are important treatment for ischaemic heart disease and heart failure; however, there has long been concern about their use in people with chronic obstructive pulmonary disease (COPD) due to fear of symptomatic worsening of br